The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression
Open accessAbstract
SUMMARY The immunosuppressive tumor microenvironment (TME) is a major barrier to immunotherapy. Within solid tumors, why monocytes preferentially differentiate into immunosuppressive tumor-associated macrophages (TAMs) rather than immunostimulatory dendritic cells (DCs) remains unclear. Using multiple murine sarcoma models, we find that the TME induces tumor cells to produce retinoic acid (RA), which polarizes intratumoral monocyte differentiation toward TAMs and away from DCs via suppression of DC-promoting transcription factor Irf4. Genetic inhibition of RA production in tumor cells or pharmacologic inhibition of RA signaling within TME increases stimulatory monocyte-derived cells, enhances T cell-dependent anti-tumor immunity, and synergizes with immune checkpoint blockade. Furthermore, an RA-responsive gene signature in human monocytes correlates with an immunosuppressive TME in multiple human tumors. RA has been considered as an anti-cancer agent, whereas our work demonstrates its tumorigenic capability via myeloid-mediated immune suppression and provides proof of concept for targeting this pathway for tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Chandrashekar, D. S., Bashel, B., Balasubramanya, S. A. H., Creighton, C. J., Ponce-Rodriguez, I., Chakravarthi, B. V. S. K., & Varambally, S. (2017) · Neoplasia · doi:10.1016/j.neo.2017.05.002 · Cited by 6,086
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
PI3Kγ is a molecular switch that controls immune suppression
Kaneda, M. M., Messer, K. S., Ralainirina, N., Li, H., Leem, C. J., Gorjestani, S., Woo, G., Nguyen, A. V., Figueiredo, C. C., Foubert, P., et al. (2016) · Nature · doi:10.1038/nature19834 · Cited by 1,173
Retinoic Acid Synthesis and Signaling during Early Organogenesis
Duester, G. (2008) · Cell · doi:10.1016/j.cell.2008.09.002 · Cited by 1,098
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Cubillos-Ruiz, J. R., Silberman, P. C., Rutkowski, M. R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S. E., Gupta, D., Holcomb, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.025 · Cited by 933
Okabe, Y., & Medzhitov, R. (2014) · Cell · doi:10.1016/j.cell.2014.04.016 · Cited by 884
Helft, J., Böttcher, J., Chakravarty, P., Zelenay, S., Huotari, J., Schraml, B. U., Goubau, D., & Reis e Sousa, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.018 · Cited by 812
Development and Function of Dendritic Cell Subsets
Mildner, A., & Jung, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.04.016 · Cited by 767
Fatty acid transport protein 2 reprograms neutrophils in cancer
Veglia, F., Tyurin, V. A., Blasi, M., De Leo, A., Kossenkov, A. V., Donthireddy, L., To, T. K. J., Schug, Z., Basu, S., Wang, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1118-2 · Cited by 751
Self-citationSatpathy, A. T., KC, W., Albring, J. C., Edelson, B. T., Kretzer, N. M., Bhattacharya, D., Murphy, T. L., & Murphy, K. M. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120030 · Cited by 632
Retinoids, Retinoic Acid Receptors, and Cancer
Tang, X.-H., & Gudas, L. J. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130303 · Cited by 596
Monocyte heterogeneity and functions in cancer
Olingy, C. E., Dinh, H. Q., & Hedrick, C. C. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4ri0818-311r · Cited by 579
Abram, C. L., Roberge, G. L., Hu, Y., & Lowell, C. A. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.05.009 · Cited by 506
Dendritic cells in cancer: the role revisited
Veglia, F., & Gabrilovich, D. I. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.01.002 · Cited by 443
Advances in sarcoma genomics and new therapeutic targets
Taylor, B. S., Barretina, J., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3087 · Cited by 427
Mechanism of All- Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
Nefedova, Y., Fishman, M., Sherman, S., Wang, X., Beg, A. A., & Gabrilovich, D. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2593 · Cited by 423
Gubin, M. M., Esaulova, E., Ward, J. P., Malkova, O. N., Runci, D., Wong, P., Noguchi, T., Arthur, C. D., Meng, W., Alspach, E., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.030 · Cited by 419
Aryl hydrocarbon receptor Controls Monocyte Differentiation into dendritic Cells versus Macrophages
Goudot, C., Coillard, A., Villani, A.-C., Gueguen, P., Cros, A., Sarkizova, S., Tang-Huau, T.-L., Bohec, M., Baulande, S., Hacohen, N., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.016 · Cited by 382
Li, T., Su, Y., Mei, Y., Leng, Q., Leng, B., Liu, Z., Stass, S. A., & Jiang, F. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.127 · Cited by 362
Retinoic Acid Enhances Foxp3 Induction Indirectly by Relieving Inhibition from CD4+CD44hi Cells
Hill, J. A., Hall, J. A., Sun, C.-M., Cai, Q., Ghyselinck, N., Chambon, P., Belkaid, Y., Mathis, D., & Benoist, C. (2008) · Immunity · doi:10.1016/j.immuni.2008.09.018 · Cited by 357
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
Haldar, M., Hancock, J. D., Coffin, C. M., Lessnick, S. L., & Capecchi, M. R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.016 · Cited by 326
Self-citationCommentary: IL-4 and IL-13 receptors and signaling
McCormick, S. M., & Heller, N. M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.023 · Cited by 317
A spatially and temporally restricted mouse model of soft tissue sarcoma
Kirsch, D. G., Dinulescu, D. M., Miller, J. B., Grimm, J., Santiago, P. M., Young, N. P., Nielsen, G. P., Quade, B. J., Chaber, C. J., Schultz, C. P., et al. (2007) · Nature Medicine · doi:10.1038/nm1602 · Cited by 301
Menezes, S., Melandri, D., Anselmi, G., Perchet, T., Loschko, J., Dubrot, J., Patel, R., Gautier, E. L., Hugues, S., Longhi, M. P., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.12.001 · Cited by 291
Retinoic Acid and Immune Homeostasis: A Balancing Act
Erkelens, M. N., & Mebius, R. E. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.12.006 · Cited by 255
Host tissue determinants of tumour immunity
Salmon, H., Remark, R., Gnjatic, S., & Merad, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0125-9 · Cited by 253
Quantitative Profiling of Endogenous Retinoic Acid in Vivo and in Vitro by Tandem Mass Spectrometry
Kane, M. A., Folias, A. E., Wang, C., & Napoli, J. L. (2008) · Analytical Chemistry · doi:10.1021/ac702030f · Cited by 230
Targeting of IL-4 and IL-13 receptors for cancer therapy
Suzuki, A., Leland, P., Joshi, B. H., & Puri, R. K. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.026 · Cited by 225
Retinoid signaling regulates breast cancer stem cell differentiation
Ginestier, C., Wicinski, J., Cervera, N., Monville, F., Finetti, P., Bertucci, F., Wicha, M. S., Birnbaum, D., & Charafe-Jauffret, E. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9761 · Cited by 217
Monocytes and Macrophages in Cancer: Development and Functions
Richards, D. M., Hettinger, J., & Feuerer, M. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0123-x · Cited by 210
Briseño, C. G., Haldar, M., Kretzer, N. M., Wu, X., Theisen, D. J., KC, W., Durai, V., Grajales-Reyes, G. E., Iwata, A., Bagadia, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.025 · Cited by 208
Self-citationAlcohol and aldehyde dehydrogenases: Retinoid metabolic effects in mouse knockout models
Kumar, S., Sandell, L. L., Trainor, P. A., Koentgen, F., & Duester, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.04.004 · Cited by 190
Retinoic acid controls the homeostasis of pre-cDC–derived splenic and intestinal dendritic cells
Klebanoff, C. A., Spencer, S. P., Torabi‐Parizi, P., Grainger, J. R., Roychoudhuri, R., Ji, Y., Sukumar, M., Muranski, P. J., Scott, C. D., Hall, J. A., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122508 · Cited by 164
Bhattacharya, N., Yuan, R., Prestwood, T. R., Penny, H. L., DiMaio, M. A., Reticker-Flynn, N. E., Krois, C. R., Kenkel, J. A., Pham, T. D., Carmi, Y., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.008 · Cited by 163
Gundra, U. M., Girgis, N. M., Gonzalez, M. A., Tang, M. S., van der Zande, H. J. P., Lin, J.-D., Ouimet, M. I., Lily, J., Poles, J., Vozhilla, N., et al. (2017) · Nature Immunology · doi:10.1038/ni.3734 · Cited by 145
Marcato, P., Dean, C. A., Liu, R., Coyle, K. M., Bydoun, M., Wallace, M., Clements, D. R., Turner, C., Mathenge, E. G., Gujar, S. A., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.010 · Cited by 142
Origin, development, and homeostasis of tissue‐resident macrophages
Haldar, M., & MURPHY, K. M. M. (2014) · Immunological Reviews · doi:10.1111/imr.12215 · Cited by 128
Self-citationLehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 120
Laoui, D., Overmeire, E. V., Movahedi, K., den Bossche, J. V., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., BAETSELIER, P. D., & Ginderachter, J. A. V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.007 · Cited by 105
Khoury, T., Ademuyiwa, F. O., Chandrasekhar, R., Jabbour, M., DeLeo, A. B., Ferrone, S., Wang, Y., & Wang, X. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.172 · Cited by 100
Vellozo, N. S., Pereira-Marques, S. T., Cabral-Piccin, M. P., Filardy, A. A., Ribeiro-Gomes, F. L., Rigoni, T. S., DosReis, G. A., & Lopes, M. F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01560 · Cited by 87
ALDH1A1 overexpression is associated with the progression and prognosis in gastric cancer
Li, X.-S., Xu, Q. R., Fu, X., & Luo, W. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-705 · Cited by 82
The Emerging Understanding of Myeloid Cells as Partners and Targets in Tumor Rejection
Broz, M. L., & Krummel, M. F. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0041 · Cited by 79
Retinoic Acid Signaling Coordinates Macrophage-Dependent Injury and Repair after AKI
Chiba, T., Skrypnyk, N. I., Skvarca, L. B., Penchev, R., Zhang, K. X., Rochon, E. R., Fall, J. L., Paueksakon, P., Yang, H., Alford, C. E., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111108 · Cited by 77
Mohty, M., Morbelli, S. D., Isnardon, D., Sainty, D., Arnoulet, C., Gaugler, B., & Olive, D. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04489.x · Cited by 69
Zhang, W., Yan, W., You, G., Bao, Z., Wang, Y., Liu, Y., You, Y., & Jiang, T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.033 · Cited by 65
Bhatt, S., Qin, J., Bennett, C. D., Qian, S., Fung, J. J., Hamilton, T. A., & Lü, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303073 · Cited by 61
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas
Schreiber, T. H., & Podack, E. R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605198 · Cited by 55
Barrott, J. J., Illum, B. E., Jin, H., Zhu, J.-F., Mosbruger, T., Monument, M. J., Smith-Fry, K., Cable, M. G., Wang, Y., Grossmann, A. H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4283 · Cited by 36
Microenvironmental Targets in Sarcoma
Ehnman, M., & Larsson, O. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00248 · Cited by 24
Cited by
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
The hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
Neutrophil extracellular traps in homeostasis and disease
Wang, H., Kim, S. J., Lei, Y., Wang, S., Wang, H., Huang, H., Zhang, H., & Tsung, A. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01933-x · Cited by 537
Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages
Chen, D., Zhang, X., Li, Z., & Zhu, B. (2021) · Theranostics · doi:10.7150/thno.51777 · Cited by 390
Metadata
- Authors
- Devalaraja, S., To, T. K. J., Folkert, I. W., Natesan, R., Alam, M. Z., Li, M., Tada, Y., Budagyan, K., Dang, M. T., Zhai, L., Lobel, G. P., Ciotti, G. E., Eisinger-Mathason, T. S. K., Asangani, I. A., Weber, K., Simon, M. C., & Haldar, M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 180
- Issue
- 6
- Pages
- 1098-1114.e16
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3012041454
- Cited by
- 257
- References
- 55
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.